PACS Group, Inc. Investors: Company Investigated by the Portnoy Law Firm

Core Insights - PACS Group, Inc. is under investigation for possible securities fraud following allegations of fraudulent practices related to its turnaround strategy for skilled nursing facilities [3][4] - The company's stock price experienced a significant decline of 27.8%, dropping by $11.93 to close at $31.01 per share on November 4, 2024, leading to substantial losses for investors [4] Investigation Details - Hindenburg Research released a report on November 4, 2024, accusing PACS of exploiting taxpayer-funded healthcare programs and misusing a COVID-era waiver [3] - Allegations include improper billing of Medicare Part B for unnecessary therapies and employing unlicensed administrators [3] Legal Actions - The Portnoy Law Firm has initiated an investigation and may file a class action on behalf of PACS investors who incurred losses [1] - Investors are encouraged to contact the law firm for a complimentary case evaluation and to discuss their legal rights [2][5]